Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
03/21/2012 | CN102085251B Medicinal composition for treating hepatitis |
03/21/2012 | CN102078532B Chinese medicine composition for treating cardiac cancer |
03/21/2012 | CN101979084B Chinese medicinal composition for warming kidney and tonifying yang and preparation method thereof |
03/21/2012 | CN101972320B Method for extracting ferulic acid, chlorogenic acid and other aicd components from coptis chinensis franch |
03/21/2012 | CN101897726B Traditional Chinese medicinal powder for treating oral ulcer |
03/21/2012 | CN101874838B Medicament for treating hepatitis B, cirrhosis and hepatic ascites |
03/21/2012 | CN101856393B Application of compound Yiganling composition in aspect of auxiliary treatment of chemotherapy of tumors |
03/21/2012 | CN101850037B Medicinal composition for adjuvant therapy hepatitis |
03/21/2012 | CN101757265B Traditional Chinese medicine composition for treating persistent hepatitis and preparation method thereof |
03/21/2012 | CN101757074B Chewable tablet prepared from berberis |
03/21/2012 | CN101745023B Compound bee product and preparation method thereof |
03/21/2012 | CN101744871B Propolis Chinese medicinal preparation for treating toothaches and preparation method thereof |
03/21/2012 | CN101744782B Tablet containing faropenem sodium |
03/21/2012 | CN101721565B Health care bee product and preparation method thereof |
03/21/2012 | CN101711826B Traditional Chinese medicine composite for improving poulard productivity and application thereof |
03/21/2012 | CN101700300B Traditional Chinese medicine volatile oil composition for treating gastrointestinal dysfunction or irritable bowel syndrome (IBS), and preparation method and applications thereof in preparation of medicaments |
03/21/2012 | CN101664498B Composite traditional Chinese medicine composition and preparation method and application thereof |
03/21/2012 | CN101555283B Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions |
03/21/2012 | CN101537138B Traditional Chinese medicine hepatitis B powder for eliminating duplication of hepatitis B virus (HBV) and method for manufacturing same |
03/21/2012 | CN101463030B Method for preparing anethol trithione |
03/21/2012 | CN101455385B Nutrient food capable of stimulating the appetite and invigorating the spleen |
03/21/2012 | CN101380442B Agent for treating tummy bug and duodenum ulcer |
03/21/2012 | CN101343219B Synthesis method of Teprenone |
03/21/2012 | CN101342167B Medicament composition |
03/21/2012 | CN101292997B Pharmaceutical composition for treating empyrosis or gastric ulcer, and preparation method thereof |
03/21/2012 | CN101048502B Modified human hepatitis c virus genomic RNA having autonomous replicative competence |
03/21/2012 | CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
03/20/2012 | US8138353 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
03/20/2012 | US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
03/20/2012 | US8138311 Modified proteins, designer toxins, and methods of making thereof |
03/20/2012 | US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease. |
03/20/2012 | US8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells |
03/20/2012 | US8138147 Conditioned cell culture medium compositions and methods of use |
03/20/2012 | US8137915 Genes involved in intestinal inflammatory diseases and use thereof |
03/20/2012 | US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
03/20/2012 | US8137662 Proliferated cell lines and uses thereof |
03/20/2012 | CA2676907C Tricyclic compounds and their use as glucocorticoid receptor modulators |
03/20/2012 | CA2520109C Use of an ibat inhibitor for the treatment or prophylaxis of constipation |
03/20/2012 | CA2514507C Methods and compositions for the treatment of gastrointestinal disorders |
03/20/2012 | CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
03/20/2012 | CA2446872C Immune-modulating peptide |
03/20/2012 | CA2445785C Artificial kidney having function of metabolizing protein and method of constructing the same |
03/20/2012 | CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
03/15/2012 | WO2012034068A1 Treatment of constipation-predominant irritable bowel syndrome |
03/15/2012 | WO2012033459A1 Maturation of gastrointestinal tract |
03/15/2012 | WO2012033195A1 Heterocyclic compound |
03/15/2012 | WO2012033151A1 Composition for preventing inflammations |
03/15/2012 | WO2012032304A1 Compounds |
03/15/2012 | WO2012031978A1 Laxative containing polyethylene glycol and electrolytes |
03/15/2012 | WO2012031530A1 Use of multi-target recombinant gene and protein thereof in the prevention or treatment of helicobacter pylori infection |
03/15/2012 | WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
03/15/2012 | WO2011160062A3 Compositions and methods for treating inflammatory conditions |
03/15/2012 | WO2011118976A3 Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same |
03/15/2012 | US20120065573 Methods of Treating Vascular Lesions |
03/15/2012 | US20120065266 Oral composition |
03/15/2012 | US20120065224 Pyrrolo[3,2-c) pyridine derivatives and processes for the preparation thereof |
03/15/2012 | US20120065207 Methods for concomitant treatment of theophylline and febuxostat |
03/15/2012 | US20120065191 Pharmaceutical compounds |
03/15/2012 | US20120065189 Heterocyclic compounds for the treatment of stress-related conditions |
03/15/2012 | US20120065173 Chemical compounds |
03/15/2012 | US20120065153 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
03/15/2012 | US20120065152 Prodrugs of guanfacine |
03/15/2012 | US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis |
03/15/2012 | US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
03/15/2012 | US20120064176 Composition for preventing and treating fatty liver |
03/15/2012 | US20120064157 Pharmaceutical composition and administrations thereof |
03/15/2012 | US20120064156 Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs |
03/15/2012 | US20120064153 Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting |
03/15/2012 | US20120064152 Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same |
03/15/2012 | US20120064147 Agent for improving tissue penetration |
03/15/2012 | US20120064130 Method for impregnation with supercritical co2 |
03/15/2012 | US20120064122 Treatment of autoimmune inflammation using mir-155 |
03/15/2012 | US20120064118 Bacteria strains having a high anti-inflammatory activity |
03/15/2012 | US20120064095 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases |
03/15/2012 | US20120064091 Dysfunction of the mitochondrial respiratory chain, methods for diagnosis, treatment and follow-up |
03/15/2012 | US20120064086 High concentration antibody and protein formulations |
03/15/2012 | US20120064077 Stable and soluble antibodies inhibiting tnf alpha |
03/15/2012 | US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof |
03/15/2012 | US20120064070 Modulation of nkg2d |
03/15/2012 | US20120064062 Inhibitors of bacterial plasminogen activators |
03/15/2012 | US20120064060 Compound having s1p receptor binding potency and use thereof |
03/15/2012 | US20120064055 Methods for Treating Lysosomal Acid Lipase Deficiency in Patients |
03/15/2012 | US20120064039 Use of Guanylyl Cyclase C Agonists to Suppress Appetite |
03/15/2012 | US20120064034 Peptidomimetic protease inhibitors |
03/15/2012 | US20120064031 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases |
03/15/2012 | US20120064025 Quinazolinone Modulators Of Nuclear Receptors |
03/15/2012 | US20120063997 Delivery system with scaffolds |
03/15/2012 | US20120063996 Novel nimesulide compositions |
03/15/2012 | DE102006013624B4 Mittel zur Anwendung bei Fructoseintoleranz Means for use in fructose intolerance |
03/15/2012 | CA2811001A1 Treatment of constipation-predominant irritable bowel syndrome |
03/15/2012 | CA2810698A1 Composition for preventing inflammations |
03/15/2012 | CA2810498A1 Maturation of gastrointestinal tract |
03/14/2012 | EP2428509A1 Human adam-10 inhibitors |
03/14/2012 | EP2428217A1 Composition based on docosahexaenoic acid (dha) for use in the treatment of cystic fibrosis and non-alcoholic hepatic steatosis |
03/14/2012 | EP1605926B1 Use of pinitol for treatment of liver diseases in mammals |
03/14/2012 | EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
03/14/2012 | EP1416958B2 Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other |
03/14/2012 | EP1332218B1 Differentiation-inducing substances |
03/14/2012 | EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents |
03/14/2012 | CN202161679U 一种中药治疗合并大肠经、小肠经两组织疾病的装置 A traditional Chinese medicine treatment merge large intestine, small intestine tissue disease by two means |